Wellbutrin (Bupropion) Overdose: Clinical Manifestations and Management
Bupropion overdose is a life-threatening emergency characterized by seizures (occurring in approximately one-third of cases), cardiac complications including arrhythmias and conduction disturbances, and potential for death even with aggressive supportive care. 1
Primary Clinical Manifestations
Neurological Effects
- Seizures are the hallmark of bupropion toxicity, occurring in approximately one-third of overdose cases 1
- Seizures may be multiple and uncontrolled, potentially progressing to status epilepticus 2, 3
- Additional neurological findings include:
Cardiovascular Complications
- Sinus tachycardia is common in typical overdoses 1, 4
- ECG changes including conduction disturbances, QRS prolongation, and QTc prolongation 1, 4
- Arrhythmias of various types 1
- Paradoxical bradycardia and hypotension can occur with massive overdoses (>13 grams), representing atypical cardiotoxicity 4
- Cardiac arrest, cardiac failure, and bradycardia have been reported prior to death in fatal cases 1
Severe Systemic Complications
- Fever, muscle rigidity, and rhabdomyolysis, particularly in polydrug overdoses 1
- Hypotension, stupor, coma, and respiratory failure 1
- Transient transaminitis (liver enzyme elevation) may develop days after massive overdose 4
- Hypoxia secondary to seizures and respiratory compromise 3
Mortality Risk
Deaths have been reported with bupropion overdose alone, particularly in patients ingesting large doses 1. Fatal cases typically involve:
- Multiple uncontrolled seizures 1
- Bradycardia 1
- Cardiac failure and cardiac arrest 1
- Overdoses as low as 23 grams have resulted in death despite aggressive resuscitation 3
Critical Management Considerations
No Antidote Exists
There are no known antidotes for bupropion overdose 1. Management is entirely supportive.
Immediate Actions
- Contact Poison Control immediately (1-800-222-1222 or www.poison.org) 1
- Provide close medical supervision and monitoring 1
- Consider multiple drug overdose as a possibility 1
Resource-Intensive Care Required
- Most patients require ICU admission with median ICU/ED stay of 1.47 days per case 5
- Approximately one-third of patients require intubation 5
- GABA-A agonists (benzodiazepines) are commonly administered for seizure management 5
- Mechanical circulatory support may be necessary for refractory cardiogenic shock 2
Delayed Complications
- Pharmacobezoar formation can occur with sustained-release formulations, causing prolonged toxicity as tablets remain in the stomach 6
- Seizures may be delayed, necessitating prolonged observation periods (>24 hours) 5
- Cardiac effects may evolve from initial tachycardia to delayed bradycardia in massive overdoses 4
Common Pitfalls
- Underestimating observation time: Patients require prolonged monitoring due to delayed seizures and the extended-release formulation characteristics 5
- Missing pharmacobezoar: Sustained-release tablets can form bezoars containing 40+ tablets, causing prolonged absorption 6
- Expecting typical cardiac findings only: Massive overdoses (>13 grams) can cause paradoxical bradycardia and hypotension rather than the typical tachycardia 4
- Inadequate seizure prophylaxis: Given the one-third seizure rate, aggressive benzodiazepine administration is warranted 1, 5
Contraindications Relevant to Overdose Risk
Bupropion is contraindicated in patients with seizure disorders 7, making overdose particularly dangerous in this population. The drug should also be avoided in patients with: